Statistical approaches to experimental design and data analysis of in vivo studies

Breast Cancer Research and Treatment

Volumn 46, Issue 2-3, 1997, Pages 279-302

  Hanfelt, John J ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Bias; Cause specific failure time; Power; Repeated measures; Sample size; Survival analysis; Tumor growth

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER SURVIVAL; CAUSE OF DEATH; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; SAMPLE; STATISTICAL ANALYSIS; TREATMENT FAILURE; TUMOR GROWTH;

ANIMALS; DATA INTERPRETATION, STATISTICAL; DISEASE MODELS, ANIMAL; NEOPLASMS, EXPERIMENTAL; RANDOM ALLOCATION; RESEARCH DESIGN; STATISTICS;

EID: 0031458457     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005946614343     Document Type: Review

References (49)

1. Clarke R: Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models. Breast Cancer Res Treat 46:255-278, 1997
2. Breslow NE, Day NE: Statististical Methods in Cancer Research: Volume I - The Analysis of Case-Control Studies. IARC Scientific Publications No. 32, Lyon, 1980
3. Breslow NE, Day NE: Statististical Methods in Cancer Research: Volume II - The Design and Analysis of Cohort Studies. IARC Scientific Publications No. 82, Lyon, 1987
4. Gart JJ, Krewski D, Lee PN, Tarone RE, Wahrendorf J: Statististical Methods in Cancer Research: Volume III - The Design and Analysis of Long-Term Animal Experiments. IARC Scientific Publications No. 79, Lyon, 1986
5. Gad S, Weil CS: Statistics and Experimental Design for Toxicologists. Telford, Caldwell NJ, 1988
6. Daniel WW: Biostatistics: A Foundation for Analysis in the Health Sciences (5th Ed.). Wiley, New York, 1991
7. Brown BW, Brauner C, Chan A, Gutierrez D, Herson J, Lovato J, Polsley J: STPLAN Version 4.0 -Calculations for Sample Sizes and Related Problems. The University of Texas M.D. Anderson Cancer Center, Department of Biomathematics, 1993
8. Heitjan DF, Derr JA, Satyaswaroop PG: The multisite tumour transplantation model for human endometrial carcinoma: a statistical evaluation. Cell Prolif 25:193-203, 1992
9. StatXact 3 for Windows - Statistical Software for Exact Nonparametric Inference. CYTEL Software Corporation, Cambridge MA, 1995
10. Zimmerman DW, Zumbo BD: Parametric alternatives to the Student t-test under violations of normality and homogeneity of variance. Perceptual and Motor Skills 74:835-844, 1992
11. Zimmerman DW, Zumbo BD: The relative power of parametric and nonparametric statistical methods. In: Keren G, Lewis C (eds) A Handbook of Data Analysis in the Behavioral Sciences: Methodological Issues. Erlbaum, Hillsdale NJ, 1993, pp 481-517
12. Liang KY, Zeger S: Longitudinal data analysis using generalized linear models. Biometrika 73:13-22, 1986
13. Liang KY, Zeger S: Regression analysis for correlated data. Annu Rev Pub Health 14:43-68, 1993
14. Williams DA: Extra-binomial variation in logistic linear models. Appl Statistics 31:144-148, 1982
15. Liang KY, Hanfelt JJ: On the use of the quasi-likelihood method in teratological experiments. Biometrics 50:872-880, 1994
16. Carroll RJ, Ruppert D, Stefanski LA: Measurement Error in Nonlinear Models. Chapman and Hall, London, 1995
17. Hanfelt JJ, Liang KY: Approximate likelihoods for generalized linear errors-in-variables models. J Royal Statistical Society B 59:627-637, 1997
18. Morgan BJT: The Analysis of Quantal Response Data. Chapman and Hall, London, 1992
19. Breslow NE: Extra-Poisson variation in log-linear models. Appl Statistics 33:38-44, 1984
20. McCullagh P, Nelder JA: Generalized Linear Models (2nd Ed.). Chapman and Hall, London, 1989
21. Stephens TC: Measurement of tumor cell surviving fraction and absolute number of clonogens per tumor in excision assays. In: Kallman RF (ed) Robust Tumor Models in Experimental Cancer Therapy. Pergamon, New York, 1987, chapter 21
22. Hanauske AR, Hilsenbeck SG, Von Hoff DD: Human tumor screening. In: Teicher B (ed) Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval. Humana, Totowa NJ, 1996, chapter 3
23. Cox DR, Oakes D: Analysis of Survival Data. Chapman and Hall, London, 1984
24. Kalbfleish JD, Prentice RL: The Statistical Analysis of Failure Time Data. Wiley, New York, 1980
25. Hay JW, Wolak FA: A procedure for estimating the unconditional cumulative incidence curve and its variability for the human immunodeficiency virus. Appl Statistics 43:599-624, 1994
26. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann of Statistics 16:1141-1154, 1988
27. Aly EEAA, Kochar SC, McKeague IW: Some tests for comparing cumulative incidence functions and cause-specific hazard rates. J Amer Statistical Assoc 89:994-999, 1994
28. Lin DY: Non-parametric inference for cumulative incidence functions in competing risks studies. Statistics in Med 16:901-910, 1997
29. Lagakos SW (issue ed): Statistical methods for multiple events data in clinical trials. Statistics in Med 16(8):833-961, 1997
30. Heitjan DF, Manni A, Santen RJ: Statistical analysis of in vivo tumor growth experiments. J Cancer Res 53:6042-6050, 1993
31. Diggle PJ, Liang KY, Zeger S: Analysis of Longitudinal Data. Oxford, 1994
32. Koziol JA, Maxwell DA, Fukushima M, Colmerauer MEM, Pilch, YH: A distribution-free test for tumor-growth curve analyses with application to an animal tumor immunotherapy experiment. Biometrics 37: 383-390, 1981
33. Wei L, Lachin JM: Two-sample asymptotically distribution-free tests for incomplete multivariate observations. J Amer Statistical Assoc 79:653-661, 1984
34. Wei LJ, Johnson WE: Combining dependent tests with incomplete repeated measurements. Biometrika 72:359-364, 1985
35. Wu MC, Hunsberger S, Zucker D: Testing for differences in changes in the presence of censoring: parametric and non-parametric methods. Statistics in Med 13:635-646, 1994
36. Rygaard K, Spang-Thomsen M: Quantitation and Gompertzian analysis of tumor growth. Breast Cancer Res Treat 46:303-312, 1997
37. Garg ML, Rao BR, Redmond CK: Maximum-likelihood estimation of the parameters of the Gompertz survival function. Appl Statistics 19:152-159, 1970
38. Franses PH: Fitting a Gompertz curve (STMA V35 4508). J Operations Res 45:109-113, 1994
39. Li LY, et al: Antagonistic mutant FGF-2 proteins inhibit angiogenesis and breast cancer xenograft tumorigenesis. Proc Amer Assoc Cane Res Special Conference on Breast Cancer, Keystone CO, 1997
40. Machado SG, Robinson GA: A direct, general approach based on isobolograms for assessing the joint action of drugs in pre-clinical experiments. Statistics in Med 13:2289-2309, 1994
41. r 170,000 glycoprotein (gpl170) binding studies. J Cancer Res 54: 441-447, 1994
42. CARD for Windows: Computer Aided Research and Development by S-Matrix. Westing Software, Corte Madera CA, 1997
43. Peto R: Guidelines on the analysis of tumour rates and death rates in experimental animals. Br J Cancer 29:101-105, 1974
44. Little RJA: Modeling the drop-out mechanism in repeated-measures studies. J Am Statistical Assoc 90: 1112-1121, 1995
45. Wu MC, Bailey KR: Estimation and comparison of changes in the presence of informative right censoring: conditional linear model. Biometrics 45:939-955, 1989
46. Mori M, Woodworth GG, Woolson RF: Application of empirical Bayes inference to estimation of rate of change in the presence of informative right censoring. Statistics in Med 11:621-631, 1992
47. Mori M, Woolson RF, Woodworth GG: Slope estimation in the presence of informative right censoring: modeling the number of observations as a geometric random variable. Biometrics 50:39-50, 1994
48. Barnhart HX, Sampson AR: Multiple population models for multivariate random length data - with applications in clinical trials. Biometrics 51:195-204, 1995
49. Robins JM, Rotnitzky A, Zhao LP: Analysis of semiparametric regression models for repeated outcomes in the presence of missing data. J Am Statistical Assoc 90:106-121, 1995